Stored at -20 ℃, valid for at least 6 months;Stored at -80 ℃, valid for at least one year.
Dados avançados
Certificados(CoA,COO,BSE/TSE e Mapa de Análise)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
Calculadoras de soluções
Molarity Calculator
Determine the necessary mass, volume, or concentration for preparing a solution.
Dilution Calculator
Determine the dilution needed to prepare a stock solution.
Reconstitution Calculator
Revisões
Avaliações dos Clientes
Application Protocols
Tested applications, recommended conditions, and validated workflows specific to this SKU are Not specified for this item; refer to CoA/Spec Sheet.
Note: While general CRISPR/lentiviral procedures are described in the Reaction Conditions tab, only product-specific, validated protocols (e.g., exact selection antibiotic and concentration, MOI, or transfection recipe) should be followed for this SKU when available from the manufacturer’s documentation.
Biological Roles
Target gene context (ARG2; literature)
Function: ARG2 encodes arginase 2, a mitochondrial manganese metalloenzyme that hydrolyzes L-arginine to L-ornithine and urea. It participates in the urea/arginine–ornithine–polyamine metabolic axis, with roles in nitrogen handling and cellular redox balance.
Localization: Predominantly mitochondrial matrix; encoded in the nuclear genome and imported post-translationally via an N-terminal targeting sequence.
Isozyme complement: Distinct from ARG1 (cytosolic); ARG2 exhibits tissue-specific expression and regulation by nutrients and signaling pathways.
Pathway intersections: Influences nitric oxide (NO) bioavailability by competing with nitric oxide synthases for arginine; modulates polyamine synthesis through ornithine production; interfaces with proline and glutamate metabolism.
Relevance to CRISPR studies (general)
Knockout/knockdown of ARG2 can interrogate cellular arginine flux, mitochondrial function, and downstream effects on polyamine pools.
Overexpression or rescue experiments can dissect on-target phenotypes from off-target editing or compensatory metabolic rewiring.
Readouts: Targeted metabolomics (arginine/ornithine/urea), urea/ornithine assays, NO-related measurements, and transcriptional profiling of amino-acid metabolism genes are commonly employed.
Note: The product provides an sgRNA expression vector directed at ARG2; specific spacer sequence, species, and isoform targeting details are Not specified for this item; refer to CoA/Spec Sheet.
Buffer Applications
This product is a genetic construct rather than a buffering reagent. Conventional buffer system design (pH range, capacity, ionic strength) does not apply.
Handling buffer: If supplied in TE or nuclease-free water, that information is item-specific and Not specified for this item; refer to CoA/Spec Sheet.
For downstream cell culture work, use standard sterile PBS/DPBS and appropriate culture media as dictated by your cell line and transfection/transduction method (general guidance).
Green Alternatives
Environmental and safety considerations for CRISPR delivery (general)
Compared delivery modalities by “greenness” and risk profile (literature):
Pros: Avoids viral waste streams and helper plasmids; simpler logistics.
Cons: Lower efficiency in some primary cells; often transient.
RNP delivery (Cas9 protein + synthetic sgRNA)
Pros: No DNA; reduced off-target window; minimal integration risk; typically the lowest biohazard profile.
Cons: Costly; shorter activity window; may require nucleofection.
Greener practices
Use low-plastic workflows (reusable reservoirs where appropriate), scale-down culture volumes, and opt for serum-free or reduced-serum transfection conditions when compatible.
Choose endotoxin-free preparations to minimize cell stress and repeat experiments.
Consolidate sequencing runs and QC steps to reduce consumable use.
Trade-offs
While RNP approaches can be “greener” and safer, they may not match the stable expression achievable with lentiviral systems necessary for some long-term ARG2 studies.
Pharmaceutical Uses
This product is intended strictly for research use only.
No excipient role, compendial status, or manufacturing use is provided for this SKU. Any clinical, diagnostic, or therapeutic application is outside scope and not supported.
In general laboratory research, lentiviral CRISPR sgRNA plasmids are employed for target discovery and mechanistic studies, not for pharmaceutical formulation.
Physical Properties
Item-specific data
Appearance: Not specified for this item; refer to CoA/Spec Sheet.
Concentration/formulation (buffer, salt, pH): Not specified for this item; refer to CoA/Spec Sheet.
Extinction coefficient, A260/A280: Not specified for this item; refer to CoA/Spec Sheet.
General/literature information for plasmid DNA
Physical state: Aqueous solution (commonly in TE or nuclease-free water) or lyophilized solid; exact state for this item is Not specified for this item; refer to CoA/Spec Sheet.
Solubility: Plasmid DNA is water-soluble; insoluble in most organic solvents (literature).
Stability: Stable when frozen at −20 to −80°C; repeated freeze–thaw may shear DNA (literature).
UV absorbance: DNA λmax ≈ 260 nm; A260 of 1.0 ≈ 50 µg/mL for dsDNA (literature).
pH sensitivity: Prolonged exposure to acidic pH can depurinate DNA; EDTA chelation helps protect from nucleases (literature).
Non-applicable physicochemical properties
Boiling point, melting point (as for small molecules), density, logP, refractive index: Not applicable to high–molecular weight plasmid DNA; Not specified for this item; refer to CoA/Spec Sheet.
Practical notes (general)
Avoid metal-ion contamination and nucleases; use nuclease-free plasticware and buffers.
For accurate quantitation, use A260 with baseline correction or fluorometric dsDNA dyes; verify integrity by agarose gel or capillary electrophoresis.
Quality and Grades
Item-specific quality information
Grade/Purity: Not specified for this item; refer to CoA/Spec Sheet.
Sequence verification, endotoxin level, host strain, and antibiotic resistance marker: Not specified for this item; refer to CoA/Spec Sheet.
Context and interpretation (general/literature)
Plasmid QC practices commonly include: full plasmid sequencing or at minimum sgRNA spacer verification; restriction digest patterns; endotoxin testing for cell culture suitability; and confirmation of antibiotic resistance phenotype.
For CRISPR applications, spacer sequence accuracy is critical; even single-nucleotide deviations can impact on-target efficiency.
Low-endotoxin preparations are preferred for sensitive primary cells and for high-efficiency transfection prior to lentiviral packaging.
Implications for use
If the item is provided as a glycerol stock or bacterial stab, users typically re-streak, mini-/maxi-prep, and verify insert by Sanger sequencing before critical experiments (best practice; not item-specific).
If supplied as purified plasmid, verify concentration (A260/fluorometric) and integrity (gel) upon receipt.
Documentation
For precise attributes (vector map, antibiotic marker, selection cassette, sgRNA sequence), consult the product CoA/Spec Sheet. Do not substitute general expectations for item-specific specifications.
Reaction and Applications
Use domain (expanded from product name; general/literature)
Gene editing: Designed to express an sgRNA targeting the human ARG2 locus for CRISPR/Cas9-mediated gene knockout or transcriptional modulation when paired with Cas9 or dCas9 effectors.
Lentiviral delivery: pLenti backbones enable packaging into replication-defective lentiviral particles using helper plasmids (gag/pol, rev, VSV-G) for stable delivery to dividing and non-dividing cells (BSL-2).
Functional genomics: Supports target validation, pathway dissection, and loss-of-function studies for ARG2-related biology.
Typical workflows (general)
Cloning/verification: Confirm spacer sequence by Sanger sequencing; optional Gibson/Golden Gate to swap spacers if needed.
Transient vs stable: Transfect plasmid directly into cells expressing Cas9, or package into lentivirus for stable delivery and selection.
Selection/readouts: If vector contains an antibiotic marker or reporter (not specified here), apply appropriate selection and quantify editing by T7E1, ICE/TIDE, amplicon NGS, or targeted qPCR.
Practical tips (general)
Spacer design: Use on-target/off-target scoring tools; favor NGG-adjacent protospacers for SpCas9; avoid SNP-rich regions.
Controls: Include non-targeting and known-positive control sgRNAs; rescue by ARG2 cDNA re-expression can confirm on-target phenotypes.
Multiplexing: Dual sgRNAs can create defined deletions; ensure vector capacity and promoter compatibility.
Item-specific activity claims or performance data are not provided for this SKU; consult CoA/Spec Sheet for exact design elements.
Reaction Conditions
Item-specific reaction/operational parameters are not provided. The following are general, literature-based guidelines for lentiviral CRISPR workflows targeting genes such as ARG2.
General conditions (literature)
Plasmid propagation: Transform into a recombination-deficient E. coli strain; grow at 30–37°C; select with the appropriate antibiotic. Prepare endotoxin-reduced DNA for mammalian use.
Transfection for packaging: HEK293T cells at 60–80% confluence; co-transfect transfer plasmid with helper plasmids (e.g., psPAX2/pMD2.G) using a lipid/polymer transfection reagent per vendor instructions. Replace medium after 6–18 h; collect supernatant 48–72 h post-transfection.
Transduction: Add filtered viral supernatant with polybrene (e.g., 2–8 µg/mL, cell line dependent) to target cells; spinoculation can increase MOI. Select stably transduced cells based on vector’s selectable marker (not specified here).
Editing assessment: Harvest genomic DNA 3–7 days post-transduction (or later for stable lines); amplify target site and quantify INDELs by TIDE/ICE or NGS.
Typical ranges (illustrative, not item-specific)
MOI: 0.3–5 depending on desired single-copy vs multi-copy integration.
Temperature/CO2: 37°C, 5% CO2 for mammalian culture; biosafety level 2 for lentiviral steps.
Consult the item’s CoA/Spec Sheet for exact vector features, selection conditions, and any tested performance data.
Safety and Handling
Authoritative safety information should be obtained from the product-specific SDS.
Item-specific hazard data
GHS Classification / Signal Word / H-Statements / Pictograms: Not specified for this item; refer to SDS.
General biosafety considerations (literature/guidance)
Nature of material: Plasmid DNA encoding sgRNA is not infectious by itself. If used for lentiviral packaging, downstream work with replication-defective lentiviral particles typically requires BSL-2 containment and institutional biosafety approval.
PPE: Lab coat, gloves (nitrile), and eye protection are standard. Use biological safety cabinet (Class II) for virus production and handling of transduction steps.
Incompatibilities: Avoid nucleases (DNase) and microbial contamination. Keep away from strong acids/bases that can hydrolyze DNA.
Hygiene: Work with nuclease-free reagents and dedicated pipettes. Decontaminate surfaces with 10% bleach followed by 70% ethanol after lentiviral work.
Waste: Treat lentiviral waste as biohazard; follow institutional procedures for deactivation (e.g., bleach) prior to disposal.
First-aid overview (general)
Skin/eye contact with buffers: Rinse with water. Seek medical attention if irritation persists.
Ingestion/inhalation: Not intended for human/animal use. If exposure occurs, seek medical attention and provide SDS.
Transport/storage risks
Maintain cold chain as provided: shipped on dry ice/cold packs; store at −80°C upon receipt to preserve integrity.
Solvent Selection
This product is a plasmid DNA construct, typically supplied in an aqueous buffer or as a bacterial stock. Conventional solvent-selection guidance for small-molecule solutes is not applicable.
Applicable medium: Nuclease-free water or TE buffer are standard for plasmid handling (literature). Presence/absence of specific buffer components for this SKU is Not specified for this item; refer to CoA/Spec Sheet.
Miscibility/polarity: DNA is hydrophilic and insoluble in most organic solvents; avoid alcohol precipitation unless intentionally concentrating/purifying (literature).
Practical note: For transfection, follow reagent manufacturer guidance for complexation buffers; for lentiviral packaging, culture media compatibility, serum presence, and transfection reagent choice govern performance more than solvent polarity.
For solvent-like comparisons (not applicable): Traditional dielectric constant, Hansen parameters, or UV cutoff data are not relevant for this biological construct.
Storage and Reconstitution
Item-specific
Storage Conditions: Store at −80°C.
Shipping: Shipped on dry ice packs + cold packs, maintain cold chain upon receipt.
Reconstitution buffer, concentration, aliquot size, and thawing instructions: Not specified for this item; refer to CoA/Spec Sheet.
General handling guidance (literature)
If received as purified plasmid: Thaw on ice, briefly spin, and keep on ice during use. Aliquot to avoid repeated freeze–thaw; store working aliquots at −20°C and master stock at −80°C.
If received as bacterial glycerol stock: Streak onto selective agar, incubate 12–18 h, pick a single colony for miniprep; verify insert sequence before scale-up. Store the original glycerol stock at −80°C.
If lyophilized: Reconstitute with nuclease-free water or TE to desired concentration (e.g., 50–200 ng/µL); allow to fully dissolve on ice before use.
Avoid repeated freeze–thaw cycles; use low-adhesion, nuclease-free tubes and tips; include EDTA (0.1–1 mM) in long-term storage buffers to chelate divalent cations.
Always consult the product’s CoA/Spec Sheet for any item-specific storage buffer composition and reconstitution instructions.
Structure and Identity
Overview: pLenti-ARG2-sgRNA is a lentiviral CRISPR/Cas9 guide RNA plasmid designed to express a single guide RNA (sgRNA) targeting the ARG2 gene (arginase 2).
Item-specific identifiers
CAS: Not specified for this item; refer to CoA/Spec Sheet.
Molecular Formula: Not specified for this item; refer to CoA/Spec Sheet.
Molecular Weight: Not specified for this item; refer to CoA/Spec Sheet.
InChIKey / SMILES / CID: Not applicable to plasmid DNA constructs.
Structural features (general, literature)
Backbone: Typical pLenti vectors include a 5′ and 3′ LTR, packaging signal (Psi), and selectable markers; exact map/features for this SKU are Not specified for this item; refer to CoA/Spec Sheet.
Functional cassette: U6 or H1 promoter–driven sgRNA scaffold with a gene-specific spacer sequence for ARG2. The specific spacer sequence and scaffold version are Not specified for this item; refer to CoA/Spec Sheet.
Optional elements often present in pLenti CRISPR systems (literature): antibiotic resistance marker (e.g., puromycin or blasticidin), fluorescent reporter, origin(s) of replication for E. coli, and WPRE/CMV promoters. Presence/absence for this item is Not specified for this item; refer to CoA/Spec Sheet.
2D description in words (general)
Circular double-stranded DNA plasmid comprising modular transcription units: a Pol III promoter driving the sgRNA (spacer + tracrRNA scaffold), flanked by lentiviral cis-acting sequences to enable packaging into VSV-G–pseudotyped lentiviral particles when co-transfected with helper plasmids. No small-molecule stereochemistry applies.
Synthetic Utility
Not a small-molecule building block; conventional synthetic utility (as a reagent/intermediate) does not apply.
Molecular biology utility (general)
Vector engineering: Backbone can serve as a template for cloning alternative ARG2-targeting spacers or multiplex sgRNA cassettes via Golden Gate or Gibson assembly.
Modular swaps: Promoter or selection cassettes can be exchanged if compatible restriction sites or homology arms are available (item-specific map Not specified for this item; refer to CoA/Spec Sheet).
Readout integration: Reporter elements or barcodes can be inserted for pooled screening or lineage tracing, subject to vector capacity constraints (literature).
Note: Do not infer the presence of specific cloning sites or cassettes for this SKU without consulting the provided plasmid map/CoA.
Target Specificity
Item-specific targeting details
sgRNA spacer sequence, PAM context, species/isoform targeting, and verified on-target site: Not specified for this item; refer to CoA/Spec Sheet.
General notes (literature)
ARG2 targeting: Effective sgRNAs typically target early constitutive exons shared by major transcripts to maximize knockout probability; PAM compatibility (e.g., NGG for SpCas9) is required.
Off-target risk: In silico design should minimize sequence similarity to non-target loci; empirical validation via amplicon sequencing at predicted off-targets is recommended.
This section is not analogous to antibody target reactivity (antigen/epitope/clone/isotype) because the product is a nucleic-acid vector rather than an antibody.
Usamos cookies para garantir o funcionamento adequado do site e, quando permitido, para melhorar a sua experiência. Você pode gerenciar suas preferências a qualquer momento nas Configurações. Saiba mais em nossa Política de Cookies.
Deseja que lhe enviemos uma mensagem quando tivermos descontos disponíveis?
Lembrar-me mais tarde
Obrigado! Por favor, verifique a sua caixa de entrada de e-mail para confirmar.
Products are supplied to verified businesses, institutions, and qualified professionals for research and development use only. Not for use in humans, animals, diagnosis, or therapy.